LYMPHOPROLIFERATIVE DISORDERS
Clinical trials for LYMPHOPROLIFERATIVE DISORDERS explained in plain language.
Never miss a new study
Get alerted when new LYMPHOPROLIFERATIVE DISORDERS trials appear
Sign up with your email to follow new studies for LYMPHOPROLIFERATIVE DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune therapy takes on Epstein-Barr virus in hard-to-treat patients
Disease control OngoingThis study tests an experimental cell therapy called tabelecleucel in 190 people with diseases caused by the Epstein-Barr virus, including certain lymphomas and post-transplant complications. The treatment uses specially trained immune cells to attack virus-infected cells. The ma…
Matched conditions: LYMPHOPROLIFERATIVE DISORDERS
Phase: PHASE2 • Sponsor: Pierre Fabre Medicament • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
Engineered immune cells aim to stop lymphoma relapse after transplant
Disease control OngoingThis early-phase study tests a treatment that adds a special antibody to a patient's own immune cells (T cells) to help them find and attack lymphoma cells. The goal is to find a safe dose of these modified cells to give after a stem cell transplant, to try to prevent the cancer …
Matched conditions: LYMPHOPROLIFERATIVE DISORDERS
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
Could a donor stem cell transplant fix broken immune systems?
Disease control OngoingThis study tests whether a stem cell transplant from a healthy donor can safely treat people with severe T-cell problems. Participants receive chemotherapy and antibody therapy before the transplant to prepare their body, then donor stem cells are given to build a new, healthy im…
Matched conditions: LYMPHOPROLIFERATIVE DISORDERS
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC
-
Engineered immune cells get a navigation system to hunt lymphoma
Disease control OngoingThis early-phase study tests a new treatment for people with certain lymphomas that have come back or not responded to standard therapy. The treatment uses a patient's own immune cells (T cells) that are modified in the lab to recognize and attack cancer cells, plus an added navi…
Matched conditions: LYMPHOPROLIFERATIVE DISORDERS
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 09, 2026 12:10 UTC
-
Engineered immune cells take aim at Hard-to-Treat lymphomas
Disease control OngoingThis study tests a new treatment for people with Hodgkin or non-Hodgkin lymphoma that has returned or not responded to standard therapies. The treatment uses the patient's own immune cells (T cells) that are modified in a lab to recognize and attack cancer cells carrying a marker…
Matched conditions: LYMPHOPROLIFERATIVE DISORDERS
Phase: PHASE1, PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 09, 2026 12:07 UTC
-
Massive study seeks root causes of blood cancers
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to uncover why blood and bone marrow cancers develop by analyzing genetic and protein abnormalities in cancer cells. Researchers will collect samples from 5,000 people with these cancers to identify key mutations and test if existing drugs can reverse them. Partic…
Matched conditions: LYMPHOPROLIFERATIVE DISORDERS
Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:05 UTC